Clinical and molecular hepatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Changing from NAFLD to MASLD: Similar Cumulative Incidence of Reflux Esophagitis between NAFLD and MASLD
Clin Mol Hepatol. 2023 Dec 4. doi: 10.3350/cmh.2023.0437. Online ahead of print.NO ABSTRACTPMID:38044039 | DOI:10.3350/cmh.2023.0437 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - December 3, 2023 Category: Gastroenterology Authors: Shuhei Fukunaga Michita Mukasa Dan Nakano Tsubasa Tsutsumi Takumi Kawaguchi Source Type: research

Correspondence on a Letter regarding "Waiting for the changes after the adoption of steatotic liver disease (MASLD)"
Clin Mol Hepatol. 2023 Nov 28. doi: 10.3350/cmh.2023.0500. Online ahead of print.NO ABSTRACTPMID:38016440 | DOI:10.3350/cmh.2023.0500 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - November 28, 2023 Category: Gastroenterology Authors: Eileen L Yoon Dae Won Jun Source Type: research

Cardiovascular Risk in Chronic Hepatitis B Patients Treated with Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide
CONCLUSIONS: Patients treated with TAF had comparable risks of cardiovascular outcomes, defined as MACE, as patients treated with TDF.PMID:37981763 | DOI:10.3350/cmh.2023.0328 (Source: Clinical and molecular hepatology)
Source: Clinical and molecular hepatology - November 20, 2023 Category: Gastroenterology Authors: Hyeyeon Hong Won-Mook Choi Danbi Lee Ju Hyun Shim Kang Mo Kim Young-Suk Lim Han Chu Lee Jonggi Choi Source Type: research